CAPECITABINE TEVA  150 MG Israeli - Kiingereza - Ministry of Health

capecitabine teva 150 mg

abic marketing ltd, israel - capecitabine - film coated tablets - capecitabine 150 mg - capecitabine - adjuvant colon cancer: capecitabine teva® is indicated for the adjuvant treatment of patients following surgery of stage iii (dukesע stage c) colon cancer. colorectal cancer: capecitabine teva® is indicated for the treatment of patients with advanced or metastatic colorectal cancer. advanced gastric cancer: capecitabine teva® is indicated for first line treatment of advanced gastric cancer in combination with chemotherapy. breast cancer combination therapy: capecitabine teva® in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. breast cancer monotherapy: capecitabine teva® is also indicated for the treatment of advanced or metastatic breast cancer after failure of standard therapy including a taxane unless therapy with a taxane is clinically contraindicated.

CAPECITABINE TEVA  500 MG Israeli - Kiingereza - Ministry of Health

capecitabine teva 500 mg

abic marketing ltd, israel - capecitabine - film coated tablets - capecitabine 500 mg - capecitabine - adjuvant colon cancer: capecitabine teva® is indicated for the adjuvant treatment of patients following surgery of stage iii (dukes stage c) colon cancer. colorectal cancer: capecitabine teva® is indicated for the treatment of patients with advanced or metastatic colorectal cancer. advanced gastric cancer: capecitabine teva® is indicated for first line treatment of advanced gastric cancer in combination with chemotherapy. breast cancer combination therapy: capecitabine teva® in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. breast cancer monotherapy: capecitabine teva® is also indicated for the treatment of advanced or metastatic breast cancer after failure of standard therapy including a taxane unless therapy with a taxane is clinically contraindicated.

S-1 25 25 mg/7.25 mg/24.5 mg Capsule Filipino - Kiingereza - FDA (Food And Drug Administration)

s-1 25 25 mg/7.25 mg/24.5 mg capsule

taiho pharma singapore pte. ltd.; importer: zuellig pharma corporation.; distributor: zuellig pharma corporation. - tegafur gimeracil , oteracil potassium - capsule - 25 mg/7.25 mg/24.5 mg

S-1 20 20 mg/5.8 mg/19.6 mg Capsule Filipino - Kiingereza - FDA (Food And Drug Administration)

s-1 20 20 mg/5.8 mg/19.6 mg capsule

taiho pharma singapore pte. ltd.; importer: zuellig pharma corporation; distributor: zuellig pharma corporation - tegafur gimeracil oteracil potassium - capsule - 20 mg/5.8 mg/19.6 mg

ESUEEWAN OD Tablets T20 (エスエーワン配合OD錠T20) Japani - Kiingereza - すりの適正使用協議会 RAD-AR Council, Japan

esueewan od tablets t20 (エスエーワン配合od錠t20)

sawai pharmaceutical co.,ltd. - tegafur; gimeracil; oteracil potassium - light blue-green tablet, diameter: 7.1 mm, thickness: 3.2 mm

ESUEEWAN OD Tablets T25 (エスエーワン配合OD錠T25) Japani - Kiingereza - すりの適正使用協議会 RAD-AR Council, Japan

esueewan od tablets t25 (エスエーワン配合od錠t25)

sawai pharmaceutical co.,ltd. - tegafur; gimeracil; oteracil potassium - light orange tablet, diameter: 7.6 mm, thickness: 3.5 mm

Futraful capsule 200mg (フトラフールカプセル200mg) Japani - Kiingereza - すりの適正使用協議会 RAD-AR Council, Japan

futraful capsule 200mg (フトラフールカプセル200mg)

taiho pharmaceutical co.,ltd. - tegafur - white capsule, whole length: 16.0 mm, major axis: 5.8 mm, minor axis: 5.5 mm